Booth SL. Roles for Vitamin K beyond coagulation. Annu Rev Nutr 2009;29:89-110.
Shearer MJ, Newman P. Metabolism and cell biology of Vitamin K. Thromb Haemost 2008;100:530-47.
Booth SL. Vitamin K: food composition and dietary intakes. Food Nutr Res 2012;56. doi: 10.3402/fnr.v56i0.5505.
.Elder SJ, Haytowitz DB, Howe J, Peterson JW, Booth SL. Vitamin k contents of meat, dairy, and fast food in the US diet. J Agric Food Chem 2006;54:463-7.
Sakano T, Nagaoka T, Morimoto A, Hirauchi K. Measurement of K Vitamins in human and animal feces by high-performance liquid chromatography with fluorometric detection. Chem Pharm Bull (Tokyo) 1986;34:4322-6.
Kaneki M, Hodges SJ, Hosoi T, Fujiwara S, Lyons A, Crean SJ, et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of Vitamin K2: possible implications for hip-fracture risk. Nutrition 2001;17:315-21.
Azharuddin MK, O'Reilly DS, Gray A, Talwar D. HPLC method for plasma Vitamin K1: effect of plasma triglyceride and acutephase response on circulating concentrations. Clin Chem 2007;53:1706-13.
Shea MK, Booth SL. Concepts and controversies in evaluating Vitamin K status in population-based studies. Nutrients 2016;8:pii:E8.
Booth SL, Suttie JW. Dietary intake and adequacy of Vitamin K. J Nutr 1998;128:785-8.
Institute of Medicine (US) Panel on Micronutrients. Dietary reference intakes for Vitamin A, Vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington (DC): National Academies Press (US); 2001. Available from: http://www.ncbi.nlm.nih.gov/books/NBK222310/ doi: 10.17226/10026.
Available at: http://www.sinu.it/html/pag/10-VITAMINE-2.asp. Accessed 20 Mar 2016.
Expert Group on Vitamins and Minerals. Safe Upper Levels for Vitamins and Minerals. Vitamin K. 2003; pp 154-161. Available at: http://cot.food.gov.uk/sites/default/files/vitmin2003.pdf. Accessed 20 Mar 2016.
Committee on Medical Aspects of Food and Nutrition Policy (COMA). Dietary reference values for food energy and nutrients for the United Kingdom. Report of the panel on dietary reference values. HMSO, London; 1991.
Oldenburg J, Marinova M, Muller-Reible C, Watzka M. The Vitamin K cycle. Vitam Horm 2008;78:35-62.
Fusaro M, Crepaldi G, Maggi S, Galli F, D'Angelo A, Calo L, et al. Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship. J Endocrinol Invest 2011;34:317-23.
Traber MG. Vitamin E and K interactions: a 50-year-old problem. Nutr Rev 2008;66:624-9.
Tabb MM, Sun A, Zhou C, Grun F, Errandi J, Romero K, et al. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003;278:43919-27.
Landes N, Birringer M, Brigelius-Flohe R. Homologous metabolic and gene activating routes for Vitamins E and K. Mol Aspects Med 2003;24:337-44.
Azuma K, Casey SC, Urano T, Horie-Inoue K, Ouchi Y, Blumberg B, et al. Pregnane X receptor knockout mice display aging-dependent wearing of articular cartilage. PLoS One 2015;10:e0119177.
Thijssen HH, Drittij-Reijnders MJ. Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br J Nutr 1996;75:121-7.
Okano T, Shimomura Y, Yamane M, Suhara Y, Kamao M, Sugiura M, et al. Conversion of phylloquinone (Vitamin-K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 2008;83:11270-9.
Nakagawa K, Hirota Y, Sawada N, Yuge N, Watanabe M, Uchino Y, et al. Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature 2010;468:117-121.
Yamamoto R, Komai M, Kojima K, Furukawa Y, Kimura S. Menaquinone-4 accumulation in various tissues after an oral administration of phylloquinone in Wistar rats. J Nutr Sci Vitaminol (Tokyo) 1997;43:133-43.
Lamon-Fava S, Sadowski JA, Davidson KW, O'Brien ME, McNamara JR, Schaefer EJ. Plasma lipoproteins as carriers of phylloquinone (Vitamin K1) in humans. Am J Clin Nutr 1998;67:1226-31.
Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K Vitamins in healthy subjects. Biochim Biophys Acta 2002;1570:27-32.
Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997;38:2173-92.
Niemeier A, Niedzielska D, Secer R, Schilling A, Merkel M, Enrich C, et al. Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function. Bone 2008;43:230-7.
Gundberg CM, Nieman SD, Abrams S, Rosen H. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 1998;83:3258-66.
McKeown NM, Jacques PF, Gundberg CM, Peterson JW, Tucker KL, Kiel DP, et al. Dietary and nondietary determinants of Vitamin K biochemical measures in men and women. J Nutr 2002;132:329-34.
Buranasinsup S, Bunyaratavej N. The intriguing correlation between undercarboxylated osteocalcin and Vitamin D. J Med Assoc Thai 2015;98(Suppl 8):S16-20.
Schlieper G1, Westenfeld R, Kruger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, et al. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011;22:387-95.
Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S, et al. Effect of Vitamin K2 supplementation on functional Vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012;59:186-95.
Caluwe R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol Dial Transplant 2014;29:1385-90.
Boxma PY, van den Berg E, Geleijnse JM, Laverman GD, Schurgers LJ, Vermeer C, et al. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients. PLoS One 2012;7:e47991.
Cranenburg EC, Koos R, Schurgers LJ, Magdeleyns EJ, Schoonbrood TH, Landewe RB, et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010;104:811-22.
Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Medart L, et al. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of Vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol 2014;15:145.
Delanaye P, Dubois BE, Lukas P, Peters P, Krzesinski JM, Pottel H, et al. Impact of stopping Vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein. Clin Chem Lab Med 2015;53:e191-3.
Teruya M, Soundar E, Hui SR, Eldin K, Adcock D, Teruya J. PIVKAII correlates with INR but not protein C or protein S concentrations in cord blood among newborns. J Neonatal Perinatal Med 2016;9:139-43.
Harrington DJ, Booth SL, Card DJ, Shearer MJ. Excretion of the urinary 5C-and 7C-aglycone metabolites of Vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 2007;137:1763-8.
Harrington DJ, Clarke P, Card DJ, Mitchell SJ, Shearer MJ. Urinary excretion of Vitamin K metabolites in term and preterm infants: relationship to Vitamin K status and prophylaxis. Pediatr Res 2010;68:508-12.
Ducros V, Pollicand M, Laporte F, Favier A. Quantitative determination of plasma Vitamin K1 by high-performance liquid chromatography coupled to isotope dilution tandem mass spectrometry. Anal Biochem 2010;401:7-14.
Olson RE. The function and metabolism of Vitamin K. Annu Rev Nutr 1984;4:281-337.
Shino M. Determination of endogenous Vitamin K (phylloquinone and menaquinone-n) in plasma by high-performance liquid chromatography using platinum oxide catalyst reduction and fluorescence detection. Analyst 1988;113:393-7.
Kamao M, Suhara Y, Tsugawa N, Okano T. Determination of plasma Vitamin K by high performance liquid chromatography with fluorescence detection using Vitamin K analogs as internal standards. J Chromatogr B Analyt Technol Biomed Life Sci 2005;816:41-8.
Paroni R, Faioni EM, Razzari C, Fontana G, Cattaneo M. Determination of Vitamin K1 in plasma by solid phase extraction and HPLC with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:351-4.
Suhara Y, Kamao M, Tsugawa N, Okano T. Method for the determination of Vitamin K homologues in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem 2005;77:757-63.
Gentili A, Cafolla A, Gasperi T, Bellante S, Caretti F, Curini R, et al. Rapid, high performance method for the determination of Vitamin K (1), menaquinone-4 and Vitamin K (1) 2,3-epoxide in human serum and plasma using liquid chromatography-hybrid quadrupole linear ion trap mass spectrometry. J Chromatogr A 2014;1338:102-10.
Karl JP, Fu X, Dolnikowski GG, Saltzman E, Booth SL. Quantification of phylloquinone and menaquinones in feces, serum, and food by high-performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2014;963:128-33.
Riphagen IJ, Van der Molen JC, Van Faassen M, Navis G, De Borst MH, Muskiet FA, et al. Measurement of plasma Vitamin K1 (Phylloquinone) and K2 (Menaquinones-4 and-7) using HPLC-tandem mass spectrometry. Clin Chem Lab Med 2016;54:1201-10.
Cham BE, Smith JL, Colquhoun DM. Interdependence of serum concentrations of Vitamin K1, Vitamin E, lipids, apolipoprotein A1, and apolipoprotein B: Importance in assessing Vitamin status. Clin Chim Acta 1999;287:45-57.
Wakabayashi H, Nakajima M, Yamato S, Shimada K. Determination of idebenone in rat serum and brain by highperformance liquid chromatography using platinum catalyst reduction and electrochemical detection. J Chromatogr 1992;573:154-7.
MacCrehan WA, Durst RA. Dual-electrode, liquid chromatographic detector for the determination of analytes with high redox potentials. Anal Chem 1981;53:1700-4.
Fusaro M, Noale M, Viola V, Galli F, Tripepi G, Vajente N, et al. Vitamin K, vertebral fractures, vascular calcifications and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Mineral Res 2012;27:2271-8.
Card DJ, Shearer MJ, Schurgers LJ, Harrington DJ. The external quality assurance of phylloquinone (Vitamin K (1)) analysis in human serum. Biomed Chromatogr 2009;23:1276-82.
Koitaya N, Ezaki J, Nishimuta M, Yamauchi J, Hashizume E, Morishita K, et al. Effect of low dose Vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. J Nutr Sci Vitaminol (Tokyo) 2009;55:15-21.
Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J 2012;11:93.
Neogi T, Booth SL, Zhang YQ, Jacques PF, Terkeltaub R, Aliabadi P, et al. Low Vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum 2006;54:1255-61.
Pilkey RM, Morton AR, Boffa MB, Noordhof C, Day AG, Su Y, et al. Subclinical Vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007;49:432-9.
DiNicolantonio JJ, Bhutani J, O'Keefe JH. The health benefits of Vitamin K. Open Heart 2015;2:e000300.
Vermeer C. Vitamin K: the effect on health beyond coagulation-an overview. Food Nutr Res 2012;56. doi: 10.3402/fnr.v56i0.5329.
Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 2008;5:e196.
Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:1256-61.
Braam LA, Hoeks AP, Brouns F, Hamulyak K, Gerichhausen MJ, Vermeer C. Beneficial effects of Vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost 2004;91:373-80.
Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004;134:3100-5.
Villines TC, Hatzigeorgiou C, Feuerstein IM, O'Malley PG, Taylor AJ. Vitamin K1 intake and coronary calcification. Coron Artery Dis 2005;16:199-203.
Habu D, Shiomi S, Tamori A, Takeda T, Tanaka T, Kubo S, et al. Role of Vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. J Am Med Assoc 2004;292:358-61.
Hodges SJ, Pilkington MJ, Stamp TC. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 1991;12:387-9.
Orimo H, Shiraki M, Fujita T, Onomura T, Inoue T, Kushida K. Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis-a double blind multicenter comparative study with 1a hydroxyVitamin D3. J Bone Miner Res 1992(Suppl 1);7:S122 (Abstract).
Akiyama Y, Hara K, Ohkawa I, Tajima T. Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol 1993;62:145-53.
Hara K, Akiyama Y, Ohkawa I, Tajima T. Effects of menatetrenone on prednisolone-induced bone loss in rats. Bone 1993;14:813-8.
Koshihara Y, Hoshi K, Shiraki M. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblastlike periosteal cells by inhibiting prostaglandin H synthase activity. Biochem Pharmacol 1993;46:1355-62.
Akiyama Y, Hara K, Tajima T, Murota S, Morita I. Effect of Vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur J Pharmacol 1994;263:181-5.
Thomas DD, Krzuykowski KJ, Engelke JA, Groblewski GE. Exocrine pancreatic secretion of phospholipid, menaquinone-4, and caveolin-1 in vivo. Biochem Biophys Res Commun 2004;319:974-9.
Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol 2008;3:1504-10.
Tufano A, Coppola A, Contaldi P, Franchini M, Minno GD. Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old? Semin Thromb Hemost 2015;41:382-8.
Fusaro M, Dalle Carbonare L, Dusso A, Arcidiacono MV, Valenti MT, Aghi A, et al. Differential effects of dabigatran and warfarin on bone volume and structure in rats with normal renal function. PLoS One 2015;10:e0133847.
Shea MK, Booth SL, Massaro JM, Jacques PF, D'Agostino RB Sr, Dawson-Hughes B, et al. Vitamin K and Vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008;167:313-20.
Ohsaki Y, Shirakawa H, Hiwatashi K, Furokawa Y, Mizutani T, Komai M. Vitamin K suppresses lipopolysaccharideinduced inflammation in the rat. Biosci Biotechnol Biochem 2006;70:926-32.
